(Q36868498)

16 August 2017

1 reference

title

Mining gene expression profiles: expression signatures as cancer phenotypes (English)

1 reference

16 August 2017

Joseph R Nevins

1

1 reference

16 August 2017

Anil Potti

series ordinal

2

1 reference

16 August 2017

publication date

3 July 2007

1 reference

16 August 2017

published in

Nature Reviews Genetics

1 reference

16 August 2017

volume

8

1 reference

16 August 2017

issue

8

1 reference

16 August 2017

page(s)

601-609

1 reference

https://scigraph.springernature.com/pub.10.1038/nrg2137

16 August 2017

exact match

0 references

cites work

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

1 reference

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

31 March 2020

1 reference

31 March 2020

The Hallmarks of Cancer

1 reference

Mining for regulatory programs in the cancer transcriptome

31 March 2020

1 reference

Integrative analysis of the cancer transcriptome

31 March 2020

1 reference

Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression

31 March 2020

1 reference

Cluster analysis and display of genome-wide expression patterns

31 March 2020

1 reference

Repeated observation of breast tumor subtypes in independent gene expression data sets

31 March 2020

1 reference

Molecular portraits of human breast tumours

31 March 2020

1 reference

Multiclass cancer diagnosis using tumor gene expression signatures

31 March 2020

1 reference

Gene expression profiling identifies clinically relevant subtypes of prostate cancer

31 March 2020

1 reference

Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts

31 March 2020

1 reference

Molecular diagnosis of Burkitt's lymphoma

31 March 2020

1 reference

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

31 March 2020

1 reference

A microRNA polycistron as a potential human oncogene

31 March 2020

1 reference

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

31 March 2020

1 reference

MicroRNA expression profiles classify human cancers

31 March 2020

1 reference

MicroRNA gene expression deregulation in human breast cancer

31 March 2020

1 reference

A microRNA expression signature of human solid tumors defines cancer gene targets

31 March 2020

1 reference

MicroRNA signatures in human cancers

31 March 2020

1 reference

A molecular signature of metastasis in primary solid tumors

31 March 2020

1 reference

Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers.

31 March 2020

1 reference

Gene-expression profiles predict survival of patients with lung adenocarcinoma

31 March 2020

1 reference

A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.

31 March 2020

1 reference

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

31 March 2020

1 reference

Gene expression predictors of breast cancer outcomes

31 March 2020

1 reference

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

31 March 2020

1 reference

Prediction of central nervous system embryonal tumour outcome based on gene expression

31 March 2020

1 reference

A gene-expression signature as a predictor of survival in breast cancer

31 March 2020

1 reference

Gene expression profiling predicts clinical outcome of breast cancer

31 March 2020

1 reference

Gene expression correlates of clinical prostate cancer behavior

31 March 2020

1 reference

Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes

31 March 2020

1 reference

Predicting the clinical status of human breast cancer by using gene expression profiles

31 March 2020

1 reference

Outcome signature genes in breast cancer: is there a unique set?

31 March 2020

1 reference

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

31 March 2020

1 reference

Forensic genetics and ethical, legal and social implications beyond the clinic

31 March 2020

1 reference

The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease

31 March 2020

1 reference

Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance

31 March 2020

1 reference

Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators

31 March 2020

1 reference

Initiating oncogenic event determines gene-expression patterns of human breast cancer models

31 March 2020

1 reference

Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia

31 March 2020

1 reference

Gene expression phenotypic models that predict the activity of oncogenic pathways

31 March 2020

1 reference

An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis

31 March 2020

1 reference

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

31 March 2020

1 reference

A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer

31 March 2020

1 reference

An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.

31 March 2020

1 reference

BRAF mutation predicts sensitivity to MEK inhibition

31 March 2020

1 reference

Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer

31 March 2020

1 reference

Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer

31 March 2020

1 reference

Identification of candidate molecular markers predicting sensitivity in solid tumors to dasatinib: rationale for patient selection

31 March 2020

1 reference

Baseline gene expression predicts sensitivity to gefitinib in non-small cell lung cancer cell lines.

31 March 2020

1 reference

Gene expression patterns that predict sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer cell lines and human lung tumors

31 March 2020

1 reference

Chemosensitivity prediction by transcriptional profiling

31 March 2020

1 reference

Genomic signatures to guide the use of chemotherapeutics.

31 March 2020

1 reference

A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers.

31 March 2020

1 reference

Gene duplication: the genomic trade in spare parts

31 March 2020

1 reference

Genetic regulators of large-scale transcriptional signatures in cancer

31 March 2020

1 reference

Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma

31 March 2020

1 reference

Concordance among gene-expression-based predictors for breast cancer

31 March 2020

1 reference

The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements

31 March 2020

1 reference

Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival

31 March 2020

1 reference

Somatic mutations of the protein kinase gene family in human lung cancer

31 March 2020

1 reference

Patterns of somatic mutation in human cancer genomes

31 March 2020

1 reference

Colorectal cancer: mutations in a signalling pathway

31 March 2020

1 reference

The consensus coding sequences of human breast and colorectal cancers

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRG2137

1 reference

Dimensions Publication ID

16 August 2017

1030296429

0 references

1 reference